ストックスクリーナーアプリを入手
17.89
2.23%
0.39
アフターアワーズ：
17.89
前日終値:
$17.50
開ける：
$17.875
24時間の取引高:
235.34K
Relative Volume:
0.75
時価総額：
$607.56M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+6.42%
1か月 パフォーマンス:
+13.44%
6か月 パフォーマンス:
-40.84%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$17.75
$18.14
1週間の範囲:
$16.40
$18.14
52週間の値動き範囲:
$10.01
$32.75
Ceribell Inc Stock (CBLL) Company Profile
CBLL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
17.89 | 607.56M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-04 | 開始されました | Ladenburg Thalmann | Buy |
| 2024-11-05 | 開始されました | BofA Securities | Buy |
| 2024-11-05 | 開始されました | Canaccord Genuity | Buy |
| 2024-11-05 | 開始されました | JP Morgan | Overweight |
| 2024-11-05 | 開始されました | TD Cowen | Buy |
| 2024-11-05 | 開始されました | William Blair | Outperform |
すべてを表示
Ceribell Inc (CBLL) 最新ニュース
Nuveen Asset Management LLC Makes New Investment in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell CEO Chao Xingjuan sells $425,000 in stock By Investing.com - Investing.com Nigeria
Ceribell CEO Chao Xingjuan sells $425,000 in stock - Investing.com
Ameriprise Financial Inc. Takes Position in CeriBell (NASDAQ:CBLL) - Defense World
BNP Paribas Financial Markets Invests $43,000 in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc.: Strategic Growth and Profitability Amidst Market Challenges - TipRanks
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys Shares of 6,957 CeriBell (NASDAQ:CBLL) - Defense World
The medtech IPO window is finally open. Or is it? - MedTech Dive
CeriBell (NASDAQ:CBLL) Receives $32.50 Average Price Target from Brokerages - Defense World
Northern Trust Corp Invests $2.66 Million in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc.: Strong Q1 Performance and Promising Growth Justify Buy Rating - TipRanks
Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference - GlobeNewswire
Ceribell CEO Chao Xingjuan sells $424,000 in stock - Investing.com Australia
Ceribell CEO Chao Xingjuan sells $424,000 in stock By Investing.com - Investing.com South Africa
Tower Research Capital LLC TRC Takes $37,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell stock holds $36 target amid US-China trade deal hopes - Investing.com Canada
Ceribell stock holds $36 target amid US-China trade deal hopes By Investing.com - Investing.com South Africa
US$30.75: That's What Analysts Think CeriBell, Inc. (NASDAQ:CBLL) Is Worth After Its Latest Results - Yahoo Finance
Wells Fargo & Company MN Takes $167,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc. Earnings Call Highlights Growth and Challenges - TipRanks
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older - The Globe and Mail
AI in Clinics and Hospitals, Along with FDA Steps Signal Opportunity for Early Mover Advantages - The Globe and Mail
Earnings call transcript: CeriBell Q1 2025 revenue jumps, stock rises 6.81% - Investing.com Nigeria
Ceribell, Inc.: A Strong Buy Amidst Promising Growth and Robust Fundamentals - TipRanks
CeriBell revenue jumps 42% to USD 20.5 million in Q1 2025 - Medical Buyer
MetLife Investment Management LLC Acquires Shares of 7,749 CeriBell (NASDAQ:CBLL) - Defense World
Barclays PLC Makes New Investment in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc. Reports Strong Q1 2025 Growth - TipRanks
Ceribell, Inc. Receives Buy Rating Amid Strong Revenue Growth and Financial Performance - TipRanks
CeriBell Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: CeriBell Q1 2025 revenue jumps, stock rises 6.81% By Investing.com - Investing.com South Africa
Ceribell reports Q1 EPS (36c), consensus (46c) - TipRanks
Ceribell Reports First Quarter 2025 Financial Results - GlobeNewswire
CeriBell Inc expected to post a loss of 42 cents a shareEarnings Preview - TradingView
Invesco Ltd. Takes $252,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Legal & General Group Plc Takes Position in CeriBell (NASDAQ:CBLL) - Defense World
Analysts Set CeriBell (NASDAQ:CBLL) PT at $32.50 - Defense World
Head-To-Head Survey: CeriBell (NASDAQ:CBLL) and ADM Tronics Unlimited (OTCMKTS:ADMT) - Defense World
Ceribell Earns FedRAMP High Authorization for Its Point-of-Care EEG - Medical Product Outsourcing
41,900 Shares in CeriBell (NASDAQ:CBLL) Acquired by Renaissance Technologies LLC - Defense World
Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference - The Manila Times
CeriBell, Inc. to Present at Bank of America Securities 2025 Health Care Conference on May 14, 2025 - Nasdaq
CeriBell Gets FedRAMP High Authorization for EEG System - marketscreener.com
Ceribell Says EEG System Receives FedRAMP High Authorization - marketscreener.com
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems - The Manila Times
Ceribell Inc (CBLL) 財務データ
Ceribell Inc (CBLL) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Ceribell Inc (CBLL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Chao Xingjuan | President and CEO |
Jun 03 '25 |
Sale |
17.00 |
25,000 |
425,000 |
776,022 |
0.56%
1.70%
大文字化:
|
ボリューム (24 時間):